Towa Pharmaceutical Company Limited operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Towa Pharmaceutical Company Limited with three other
companies in this sector in JAPAN :
KYORIN Holdings, Incorporation
sales of 109.98 billion Japanese Yen [US$1.05 billion]
of which 94%
was Pharmaceutical Business),
Mochida Pharmaceutical Company Limited
(101.80 billion Japanese Yen [US$976.25 million]
of which 100%
was Pharmaceutical), and
Nippon Shinyaku Co Ltd
(116.64 billion Japanese Yen [US$1.12 billion]
of which 87%
was Pharmaceutical Products).
Towa Pharmaceutical Company Limited reported sales of ¥110.38 billion (US$1.06 billion)
March of 2020.
increase of 5.0%
versus 2019, when the company's sales were ¥105.10 billion.
Sales at Towa Pharmaceutical Company Limited have increased during each of the previous five years
(and since 2015, sales have increased a total of 54%).